Unlocking the Therapeutic Potential of Previously Undruggable Peptidergic GPCRs
Time: 11:15 am
day: Day Two
Details:
- Orion’s platform introduces efficiencies to GPCR discovery
- Developing novel molecules with optimized characteristics for drugging peptidergic GPCRs
- Diversified portfolio of preclinical and clinical programs
- AI integration for data-driven pipeline expansion
